Covishield, the vaccine candidate from Pune-based Serum Institute of India, was approved by a Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) late on Friday. Bharat Biotech has been asked to furnish more data demonstrating the efficacy of its candidate, Covaxin, an informed source confirmed to The Hindu.
You can track coronavirus cases, deaths and testing rates at the national and State levels here. A list of State Helpline numbers is available as well.
Here are live updates:
When timely care saved two COVID-19 patients at RGGGH
With pneumothorax being one of the complications in COVID-19, timely intervention by doctors saved two patients at the Rajiv Gandhi Government General Hospital (RGGGH).
One of them, a 45-year-old man, was discharged from the hospital after 103 days of treatment, while the other, a 37-year-old man, returned home after undergoing treatment for 95 days.
U.K. re-activates emergency COVID-19 hospitals, closes London primary schools
Britain reactivated emergency hospitals built at the start of the pandemic and shut primary schools in London on Friday to counter the rapid spread of a much more infectious variant of the coronavirus.
With more than 50,000 new daily cases of COVID-19 for the last four days, the health service said it was preparing for an anticipated rush of patients and needed more beds.
Source: Read Full Article